Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 21, 2025 08:00 ET | Source: Avid Bioservices, Inc

Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand

TUSTIN, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”)...
January 08, 2025 17:15 ET | Source: Avid Bioservices, Inc

Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand

TUSTIN, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”)...
January 08, 2025 09:00 ET | Source: WatchGuard Technologies, Inc

WatchGuard Acquires ActZero to Add Scalable and Open-Platform AI Security to Deliver Simplified 24/7 MDR Services

SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- WatchGuard® Technologies, a global leader in unified cybersecurity, today announced its acquisition of ActZero, a leading provider of MDR services with...
January 08, 2025 08:30 ET | Source: Accolade, Inc.

Transcarent To Acquire Accolade

Combined company creates industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment Transcarent’s Generative AI WayFinding and care...
January 06, 2025 09:00 ET | Source: Trinity Ventures

Trinity Ventures Announces Closing of $435M Continuation Fund with Partners Group, Portfolio Advisors, and funds managed by Goldman Sachs Asset Management as Anchor Investors

MENLO PARK, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Ventures, an early-stage technology venture capital firm that has championed breakthrough founders and startups for over 35 years,...
January 06, 2025 08:30 ET | Source: Outset Medical, Inc.

Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors

Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt Reports Unaudited Fourth-Quarter Revenue of $29 million and 2024 Revenue of $113 million ...
December 31, 2024 07:00 ET | Source: Galera Therapeutics

Galera Therapeutics completes acquisition of Nova Pharmaceuticals

Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of advanced breast cancer. Lead program is...
December 30, 2024 09:00 ET | Source: Avid Bioservices, Inc

Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand

TUSTIN, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”)...
December 23, 2024 08:37 ET | Source: Inmagene Biopharmaceuticals

Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement

Inmagene Biopharmaceuticals is a clinical stage company focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody with an extended half-life and a silenced ADCC function The...
December 23, 2024 08:30 ET | Source: Ikena Oncology, Inc.

Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement

Inmagene Biopharmaceuticals is a clinical stage company focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody with an extended half-life and a silenced ADCC function The...